Literature DB >> 15090199

Constitutive desensitization: a new paradigm for g protein-coupled receptor regulation.

Larry S Barak1, Alyson M Wilbanks, Marc G Caron.   

Abstract

GPCRs are a large family of cell-surface proteins that regulate many important biochemical pathways and physiological responses. The isolation and characterization of GPCRs represent one of the more remarkable success stories that occurred during the revolution in biology of the last quarter century. Of the many discoveries that originated in the laboratory of Robert Lefkowitz at Duke University concerning GPCR regulation, none is more fundamental than the elucidation of the families of GRKs and arrestin proteins that terminate GPCR signaling. In this essay, we will discuss how advances in microscopy and biology have made the visualization of GPCR, GRK, and arrestin activity possible in single cells. Additionally, we will discuss how imaging studies using arrestins and a naturally occurring mutant of the vasopressin receptor led to the recognition of a novel phenotypic receptor behavior, in which the receptor desensitizes in the absence of agonist. We have termed this process constitutive desensitization, and this unexpected receptor property suggests that it may be possible to develop novel classes of signal-inhibiting drugs distinct from conventional antagonists.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 15090199     DOI: 10.1089/15406580360545152

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  9 in total

1.  Constitutive Desensitization of Opioid Receptors in Peripheral Sensory Neurons.

Authors:  Laura C Sullivan; Teresa S Chavera; Raehannah J Jamshidi; Kelly A Berg; William P Clarke
Journal:  J Pharmacol Exp Ther       Date:  2016-09-22       Impact factor: 4.030

2.  Determinants Present in the Receptor Carboxy Tail Are Responsible for Differences in Subtype-Specific Coupling of beta-Adrenergic Receptors to Phosphoinositide 3-Kinase.

Authors:  Julie Simard; Matthieu Boucher; Rachel Massé; Terence E Hébert; Guy Rousseau
Journal:  Int J Cell Biol       Date:  2009-02-05

Review 3.  Trace amine-associated receptors as emerging therapeutic targets.

Authors:  Tatyana D Sotnikova; Marc G Caron; Raul R Gainetdinov
Journal:  Mol Pharmacol       Date:  2009-04-23       Impact factor: 4.436

4.  Decreased GRK3 but not GRK2 expression in frontal cortex from bipolar disorder patients.

Authors:  Jagadeesh S Rao; Stanley I Rapoport; Hyung-Wook Kim
Journal:  Int J Neuropsychopharmacol       Date:  2009-04-29       Impact factor: 5.176

5.  Regulation of GPR54 signaling by GRK2 and {beta}-arrestin.

Authors:  Macarena Pampillo; Natasha Camuso; Jay E Taylor; Jacob M Szereszewski; Maryse R Ahow; Mateusz Zajac; Robert P Millar; Moshmi Bhattacharya; Andy V Babwah
Journal:  Mol Endocrinol       Date:  2009-10-21

6.  Pharmacological characterization of a selective agonist for bombesin receptor subtype-3.

Authors:  Li Zhang; Hans-Peter Nothacker; Zhiwei Wang; Laura M Bohn; Olivier Civelli
Journal:  Biochem Biophys Res Commun       Date:  2009-07-04       Impact factor: 3.575

Review 7.  Molecular Regulation of Lysophosphatidic Acid Receptor 1 Maturation and Desensitization.

Authors:  Jing Zhao; Thomas Stephens; Yutong Zhao
Journal:  Cell Biochem Biophys       Date:  2021-05-25       Impact factor: 2.194

8.  Phenotypic regulation of the sphingosine 1-phosphate receptor miles apart by G protein-coupled receptor kinase 2.

Authors:  Martina Burczyk; Martin D Burkhalter; Tamara Blätte; Sabrina Matysik; Marc G Caron; Lawrence S Barak; Melanie Philipp
Journal:  Biochemistry       Date:  2015-01-15       Impact factor: 3.162

Review 9.  Making Sense of Pharmacology: Inverse Agonism and Functional Selectivity.

Authors:  Kelly A Berg; William P Clarke
Journal:  Int J Neuropsychopharmacol       Date:  2018-10-01       Impact factor: 5.176

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.